Chargement en cours...
Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study
BACKGROUND: Artemisinin-based combination therapy (ACT), the treatment of choice for uncomplicated falciparum malaria, is unaffordable and generally inaccessible in the private sector, the first port of call for most malaria treatment across rural Africa. Between August 2007 and May 2010, the Uganda...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
BioMed Central
2012
|
Sujets: | |
Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3523984/ https://ncbi.nlm.nih.gov/pubmed/23107021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1475-2875-11-356 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|